04.02.2013 • News

Solvias Acquires Confarma

Solvias announced the acquisition of Confarma, headquartered in Münchenstein, and its subsidiary Confarma France.

Solvias, a pharmaceutical service provider, is pursuing a long-term growth strategy with the aim of expanding its extensive range of services for pharmaceutical companies. By acquiring the Confarma Group, Solvias and Confarma are increasing the range of analytical services they can offer their partners in pharmaceuticals, biotechnology, and life science.

 

 

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read